Edition:
United Kingdom

Bayer AG (BAYGn.DE)

BAYGn.DE on Xetra

106.50EUR
15 Dec 2017
Change (% chg)

€1.40 (+1.33%)
Prev Close
€105.10
Open
€104.90
Day's High
€106.50
Day's Low
€104.70
Volume
6,184,479
Avg. Vol
1,904,322
52-wk High
€123.90
52-wk Low
€96.18

Select another date:

Fri, Dec 15 2017

BRIEF-Nektar Therapeutics Says Received Notice Of Termination From Bayer Of Co-Development, License, Co-Promotion Agreement

* NEKTAR THERAPEUTICS - ‍ON DEC 14, CO RECEIVED NOTICE OF TERMINATION FROM BAYER OF CO-DEVELOPMENT, LICENSE,CO-PROMOTION AGREEMENT, DATED AUG 1, 2007​ Source text: (http://bit.ly/2BsgSdG) Further company coverage:

Soccer-Bundesliga fixtures

Dec 11 (Gracenote) - Fixtures from the Bundesliga matches on Monday Tuesday, December 12 (GMT) VfL Wolfsburg v RB Leipzig (1730) Mainz v Borussia Dortmund (1930) Hamburg SV v Eintracht Frankfurt (1930) Freiburg v Borussia Moenchengladbach (1930) Wednesday, December 13 (GMT) TSG 1899 Hoffenheim v VfB Stuttgart (1730) Bayer 04 Leverkusen v Werder Bremen (1

BRIEF-Bayer's Rivaroxaban Submitted To U.S. FDA For Approval

* RIVAROXABAN SUBMITTED TO U.S. FDA FOR APPROVAL IN PATIENTS WITH CORONARY AND/OR PERIPHERAL ARTERY DISEASE Source text - http://bit.ly/2B4uKdl Further company coverage: (Gdynia Newsroom)

EU regulators to warn Bayer about Monsanto bid: source

BRUSSELS EU antitrust regulators are set to warn Bayer its planned purchase of U.S. seed maker Monsanto may hurt competition, a person familiar with the matter said on Friday, a move that would force Bayer to offer concessions to address the concerns.

UPDATE 2-EU regulators to warn Bayer about Monsanto bid -source

BRUSSELS, Dec 8 EU antitrust regulators are set to warn Bayer its planned purchase of U.S. seed maker Monsanto may hurt competition, a person familiar with the matter said on Friday, a move that would force Bayer to offer concessions to address the concerns.

EU regulators to warn Bayer about Monsanto bid - source

BRUSSELS, Dec 8 EU antitrust regulators are expected to warn Bayer in the coming weeks that its planned takeover of U.S. seed maker Monsanto may hurt competition, a person familiar with the matter said on Friday.

Jury orders Bayer, J&J to pay $28 million in Xarelto lawsuit

A Philadelphia state court jury on Tuesday ordered Bayer AG and Johnson & Johnson to pay $27.8 million to an Indiana couple over the drugmakers' failure to warn of internal bleeding risks from their blood thinner Xarelto.

Jury orders Bayer, Johnson & Johnson to pay $28 million in Xarelto lawsuit

A Philadelphia state court jury on Tuesday ordered Bayer AG and Johnson & Johnson to pay $27.8 million (£20.70 million) to an Indiana couple over the drugmakers' failure to warn of internal bleeding risks from their blood thinner Xarelto.

UPDATE 1-Jury orders Bayer, J&J to pay $28 million in Xarelto lawsuit

Dec 5 A Philadelphia state court jury on Tuesday ordered Bayer AG and Johnson & Johnson to pay $27.8 million to an Indiana couple over the drugmakers' failure to warn of internal bleeding risks from their blood thinner Xarelto.

CORRECTED-Jury orders Bayer, J&J to pay $28 million in Xarelto lawsuit

Dec 5 A Philadelphia state court jury on Tuesday ordered Bayer AG and Johnson & Johnson to pay $27.8 million to an Indiana couple over the drugmakers' failure to warn of internal bleeding risks by its blockbuster drug Xarelto.

Select another date: